Clinical trial
An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult…
NCT00274703 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00274703 |
|---|---|
| Title | An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Single-Centre Study to Provide a Preliminary Evaluation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Intravenous Anti-human Interleukin-5 (Mepolizumab, 750mg and 1500mg) in the Treatment of Eosinophilic Oesophagitis in Adults |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Oesophagitis, Eosinophilic |
| Intervention type | Drug |
| Interventions | mepolizumab |
| Enrollment | 10 |
| Start date | Dec 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 5, 2016 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: